|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:accreditation
|
gptkb:standard
|
|
gptkbp:acquisition
|
gptkb:In_Gen_Corporation
|
|
gptkbp:associated_with
|
gptkb:Jurassic_World_franchise
|
|
gptkbp:awards
|
Best Biotech Company 2022
|
|
gptkbp:benefits
|
healthcare and retirement plans
|
|
gptkbp:business_model
|
disaster recovery plans
B2 B services
|
|
gptkbp:ceo
|
gptkb:Lewis_Dodgson
|
|
gptkbp:clinical_trial
|
ongoing studies
|
|
gptkbp:collaborations
|
academic institutions
international biotech firms
|
|
gptkbp:community_engagement
|
local outreach programs
|
|
gptkbp:competitors
|
gptkb:Bio_Gen_Corporation
|
|
gptkbp:conference
|
annual biotech summit
|
|
gptkbp:cultural_representation
|
inclusive workplace policies
|
|
gptkbp:customer_base
|
pharmaceutical companies
|
|
gptkbp:customer_support
|
24/7 service
|
|
gptkbp:employees
|
500+
|
|
gptkbp:environmental_impact
|
sustainable practices
|
|
gptkbp:feedback
|
satisfaction surveys
|
|
gptkbp:field_of_study
|
gptkb:item
|
|
gptkbp:financial_performance
|
annual reports
|
|
gptkbp:focus_area
|
genetic research
|
|
gptkbp:founded
|
gptkb:2021
|
|
gptkbp:founder
|
gptkb:Lewis_Dodgson
|
|
gptkbp:future_plans
|
expand R& D capabilities
|
|
gptkbp:governed_by
|
ethical standards
|
|
gptkbp:grants
|
government funding
|
|
gptkbp:headquarters
|
gptkb:California
|
|
gptkbp:hosts_events
|
biotech networking events
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Biosyn Corporation
|
|
gptkbp:industry
|
gptkb:Company
|
|
gptkbp:innovation
|
gptkb:physicist
|
|
gptkbp:invention
|
genetic modification techniques
patents and trademarks
|
|
gptkbp:investment
|
gptkb:Company
|
|
gptkbp:market
|
biopharmaceuticals
new therapies
15% in biotech sector
biotech trends
|
|
gptkbp:notable_products
|
genetic engineering services
|
|
gptkbp:operates_in
|
gptkb:United_States
|
|
gptkbp:parent_company
|
gptkb:In_Gen_Corporation
|
|
gptkbp:partnership
|
government research projects
|
|
gptkbp:partnerships
|
healthcare providers
leading biotech firms
|
|
gptkbp:philanthropy
|
biomedical research funding
|
|
gptkbp:products
|
strict protocols
|
|
gptkbp:publishes
|
gptkb:academic_journal
|
|
gptkbp:regulatory_compliance
|
FDA regulations
|
|
gptkbp:research_areas
|
state-of-the-art labs
|
|
gptkbp:revenue
|
$1 billion+
|
|
gptkbp:risk_factor
|
biotech risks
|
|
gptkbp:social_media
|
@ Biosyn Corp
|
|
gptkbp:sponsor
|
community involvement
|
|
gptkbp:strategic_importance
|
expand global presence
|
|
gptkbp:subsidiary
|
gptkb:Bio_Syn_Genetics
|
|
gptkbp:supply_chain
|
efficient logistics
biotech suppliers
|
|
gptkbp:sustainability_initiatives
|
green biotechnology
|
|
gptkbp:technology
|
gptkb:CRISPR
research collaborations
|
|
gptkbp:training
|
advanced biotechnology courses
|
|
gptkbp:website
|
biosyn.com
|
|
gptkbp:bfsParent
|
gptkb:Dominion_Biosyn_Expansion
|
|
gptkbp:bfsLayer
|
6
|